FrankJJaconoMD

Critical Care Medicine, Pleural Disease

Associate Professor, Medicine, Case Western Reserve University School of Medicine

Dr. Jacono is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
11100 Euclid Ave
Cleveland, OH 44106
Phone+1 216-844-8500

Fax+1 216-421-3217

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1998 - 2001
Washington University in St. Louis School of MedicineClass of 1998

PubMed

Persistent glossopharyngeal nerve respiratory discharge patterns after ponto-medullary transection.
Gijnovefa Kola, Eriko Hamada, Rishi R Dhingra, Frank J Jacono, Thomas E Dick
Respiratory Physiology & Neurobiology. 2024-09-01
2 citations
Peritoneal sepsis caused by Escherichia coli triggers brainstem inflammation and alters the function of sympatho-respiratory control circuits.
Gjinovefa Kola, Caitlyn W Clifford, Cara K Campanaro, Rishi R Dhingra, Mathias Dutschmann
Journal of Neuroinflammation. 2024-02-08
Keeping Cardiac Arrest Documentation Alive in the Electronic Medical Record.
Pallavi Sharma, Gavriella Pora, Paarth Sharma, Frank J Jacono, Maroun Matta
ATS Scholar. 2023-12-01

Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDSMay 5th, 2020
Athersys and University Hospitals Cleveland Medical Center Announce Activation of the First Clinical Site for the MACOVIA Study, a Pivotal Phase 2/3 Study Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDSMay 1st, 2020
UH Cleveland Medical Center Will Be the First Clinical Site for a New Athersys Inc. TrialMay 1st, 2020
Join now to see all